A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Diabetes Patients

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 171 participants.

Also called NCT01505426

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 171 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01505426
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea, Taiwan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01505426. Randomized; quadruple masking; primary purpose treatment. Start 2011-11-28 (actual); primary completion 2013-01-14 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Diabetes Patients
Condition
Type II Diabetes Mellitus
Intervention (Drug)
ASP1941
Intervention (Drug)
metformin
Intervention (Drug)
Placebo
Lead sponsor
Astellas Pharma Inc (class: industry)

Record details

Record id
cardio:ct-nct01505426
Content hash
c6e156bffb216ffe4312cddf586a5a6200b246abec037607a5adf82c811bfda0